Adenosine A(1)-receptor induced late preconditioning and myocardial infarction: reperfusion duration is critical

Am J Physiol Heart Circ Physiol. 2002 Jul;283(1):H38-43. doi: 10.1152/ajpheart.00866.2001.

Abstract

We investigated the influence of coronary artery reperfusion (CAR) duration on the infarct-limiting properties of adenosine A(1)-receptor stimulation-induced delayed preconditioning (A(1)-DPC) compared with ischemia-induced delayed preconditioning (I-DPC). Sixty-one chronically instrumented conscious rabbits successfully underwent the following protocol. On day 1, rabbits were randomly divided into four groups: control (saline, iv), I-DPC (six 4-min coronary artery occlusion/4-min reperfusion cycles), A(1)-DPC(100) (N(6)-cyclopentyladenosine, 100 microg/kg iv), and A(1)-DPC(400) (N(6)-cyclopentyladenosine, 400 microg/kg iv). On day 2 (i.e., 24 h later), rabbits underwent a 30-min coronary artery occlusion after which CAR was started and maintained for either 3 or 72 h. Infarct size (percentage of the area at risk) was determined by triphenyltetrazolium chloride staining. After 3 h of CAR, I-DPC, A(1)-DPC(100), and A(1)-DPC(400) significantly decreased infarct size (36 +/- 5, 41 +/- 4, 38 +/- 5%, respectively) compared with control (55 +/- 3%). After 72 h of CAR, infarct sizes were not significantly different among the four groups. This result was confirmed by histologic analysis. Thus A(1)-DPC at the two investigated doses, as well as I-DPC, decreased infarct size after 3 h but not 72 h of CAR.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / pharmacology
  • Animals
  • Cardiac Catheterization
  • Coronary Vessels / physiopathology
  • Disease Models, Animal
  • Disease Progression
  • Heart Ventricles / metabolism
  • Heart Ventricles / pathology
  • Hemodynamics
  • Ischemic Preconditioning, Myocardial / methods*
  • Male
  • Myocardial Infarction / pathology
  • Myocardial Infarction / physiopathology*
  • Myocardial Infarction / prevention & control
  • Myocardial Reperfusion / methods*
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Purinergic P1 Receptor Agonists
  • Rabbits
  • Receptors, Purinergic P1 / metabolism*
  • Time Factors
  • Treatment Outcome
  • Wakefulness

Substances

  • Purinergic P1 Receptor Agonists
  • Receptors, Purinergic P1
  • N(6)-cyclopentyladenosine
  • Adenosine